Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126670) titled 'Clinical study evaluating the rate of coronary alignment and annular alignment achieved after using Peijia Medical's transcatheter aortic valve system (TaurusOne(R)/TaurusElite(R)/TaurusMax(R)) in the treatment of patients with severe aortic valve stenosis' on June 13.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: The First Affiliated Hospital of Soochow University

Condition: Severe aortic valve stenosis

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-06-22

Target Sample Size: Trial group:50;

Countries of Recruitment: China

To know more, vis...